Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC2575527/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC2575527/. The analysis below is for the second page.

Title[redir]:
The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer - PMC
Description:
Endocrine-dependent, estrogen receptor positive breast cancer cells proliferate in response to estrogens, synthesized by the cytochrome p450 aromatase enzyme. Letrozole is a potent nonsteroidal aromatase inhibitor that is registered for the ...

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

The income method remains a mystery to us.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Ncbi.nlm.nih.gov might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

cells, cancer, letrozole, doi, breast, aew, pubmed, google, scholar, growth, igfir, cell, combination, receptor, signaling, mcfaro, proliferation, factor, inhibition, insulinlike, synergistic, presence, estrogen, figure, tdaro, nmoll, res, aromatase, lane, levels, mcf, treated, concentrations, treatment, hours, values, data, study, estrogendependent, agent, cycle, igfi, table, inhibitor, vitro, steroiddeprived, versus, response, combined, tamoxifen,

Topics {✒️}

igf-ir/pi3k/pkb/akt pathway lowering phospho-pkb/akt levels selective small-molecular-weight inhibitors igf-i-dependent survival assay igf-i-dependent proliferation assays dr carlos garcia-echeverria circumventing long-term deprivation phospho-pkb/akt levels decreased steroid-deprived mcf7/aro cells blocking igf-ir auto-phosphorylation igf-ir-dependent survival pathways estrogen-dependent igf-ir signaling mediating estradiol-dependent proliferation/survival long-term estrogen deprivation poly [adp-ribose] polymerase chou-talalay derived equations trans-subunit auto-phosphorylation fluoresence-activated cell sorting fluorescence-activated cell sorting igf-ir antibody decreases pmc beta search igf-ir antibody proved estrogen-dependent breast cancers estrogen-dependent cancer setting mitogen-activated protein kinase estrogen-dependent breast cancer results estrogen-dependent proliferation growth factor-defined medium early-stage breast cancer pi3k/pkb/akt signaling steroid-deprived mcf7/aro growth factor-mediated signaling mediating estrogen-dependent proliferation aromatase-driven breast cancer igf-ir-mediated signaling competing interests er-positive tumor cells selective igf-ir inhibitor inhibits igf-ir signaling license information pmcid inhibit igf-ir signalling er-positive cells led dose-effect fit curves inhibiting androstenedione-dependent proliferation dose-dependent inhibitory effect previously endocrine-insensitive tumor estrogen-induced proliferative response t47d/aro cells accumulated induce s-phase entry anti-phospho-p44/42 mapk

Questions {❓}

  • Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?

Social Networks {👍}(6)

External Links {🔗}(128)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

4.17s.